Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $15.2 Million - $19.7 Million
580,000 New
580,000 $16.7 Million
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $6.3 Million - $8.2 Million
-160,000 Reduced 45.71%
190,000 $7.75 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $8.31 Million - $10.1 Million
-190,000 Reduced 35.19%
350,000 $16.3 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $814,275 - $965,475
17,500 Added 3.35%
540,000 $28.3 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $21.8 Million - $27.1 Million
-477,500 Reduced 47.75%
522,500 $27.1 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $19.6 Million - $25.2 Million
500,000 Added 100.0%
1,000,000 $43 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $18 Million - $20.3 Million
500,000 New
500,000 $19.6 Million
Q3 2020

Oct 13, 2020

SELL
$31.75 - $37.25 $143,129 - $167,923
-4,508 Closed
0 $0
Q2 2020

Jul 16, 2020

BUY
$30.12 - $36.54 $135,780 - $164,722
4,508 New
4,508 $147,000
Q2 2019

Jul 22, 2019

SELL
$36.98 - $41.52 $185,232 - $207,973
-5,009 Closed
0 $0
Q4 2018

Feb 05, 2019

SELL
$38.47 - $43.86 $144,070 - $164,255
-3,745 Reduced 42.78%
5,009 $219,000
Q1 2018

Apr 11, 2018

SELL
$31.91 - $37.02 $53,225 - $61,749
-1,668 Reduced 16.0%
8,754 $311,000
Q3 2017

Oct 13, 2017

BUY
$31.0 - $34.15 $323,082 - $355,911
10,422
10,422 $372,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.